BIT 1.47% 6.9¢ biotron limited

Biotron CMO appointment

  1. 2,295 Posts.
    lightbulb Created with Sketch. 271

    The Directors of Biotron Limited (‘Biotron’) are pleased to announce the appointment of Stephen L. Becker, M.D.
    to the role of Chief Medical Officer (CMO).

    Dr Becker brings to Biotron over 30 years’ experience as a clinician, researcher and product development executive
    with focus on the therapeutic areas of HIV, infectious diseases and immunology. Dr Becker undertook his medical
    training at the State University of New York at Buffalo and spent much of his career at the University of California,
    School of Medicine, San Francisco (UCSF) before transitioning to medical leadership roles in the USA and Canadian
    biotech industry. He also spent 6 years as Deputy Director in HIV at the Bill & Melinda Gates Foundation.

    Dr Becker’s connections with pharmaceutical companies, US government organisations, philanthropic organisations,
    as well as his knowledge of regulatory and policy issues relating to development and approvals of new drugs bring
    essential skills at this critical stage of the company’s development.

    “We welcome Dr Becker, and we are delighted to have someone of his calibre to advise the Company as it moves
    into the next critical stage of development of our lead HIV-1 drug, BIT225,” said Biotron’s Managing Director,
    Michelle Miller.

    Dr Becker is based in the USA and will be retained under a part-time consultancy.

    Yours sincerely
    Peter J. Nightingale
    Company Secretary
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Mkt cap ! $48.43M
Open High Low Value Volume
6.9¢ 6.9¢ 6.7¢ $32.27K 474.3K

Buyers (Bids)

No. Vol. Price($)
4 134505 6.7¢

Sellers (Offers)

Price($) Vol. No.
6.9¢ 20754 2
View Market Depth
Last trade - 15.47pm 03/03/2021 (20 minute delay) ?
0.001 ( 0.00 %)
Open High Low Volume
6.9¢ 6.9¢ 6.7¢ 116526
Last updated 13.54pm 03/03/2021 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.